TBC1D1 and colorectal carcinoma: Another study demonstrated that triple co-cultures with T-cells, CAFs, and CRC PDTOs are a good model to evaluate the anti-tumor effect of two bi-specific T-cell engagers (CEA-TBC and CEACECAM5-TBC) [33].